NCT06087549View on ClinicalTrials.gov

PENG Block vs. ESP Block for Pediatric Hip Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

February 23, 2024

Study Completion Date

February 23, 2024

Conditions
Hip DysplasiaHip InjuriesHip FracturesHip Disease
Interventions
DRUG

Pericapsular nerve group block using 0.2% ropivacaine

Unilateral ultrasound guided pericapsular nerve block using 0.5mL/kg 0.2% Ropimol (max 20mL)

DRUG

Erector Spinae Plane Block using 0.2% ropivacaine

Unilateral ultrasound guided erector spinae block using 0.5mL/kg 0.2% Ropimol (max 20mL)

OTHER

Standard care

No erector spinae block and no pericapsular nerve group block

Trial Locations (1)

61-545

Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06087549 - PENG Block vs. ESP Block for Pediatric Hip Surgery | Biotech Hunter | Biotech Hunter